Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Galantamine HBr in Adults with ADHD
NCT00181675Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Dec 2002
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in attention deficit hyperactivity disorder (ADHD) comparing Galantamine HBr with Placebo (2 arms). Primary endpoints: ADHD-Clinical Global Impression and ADHD Symptom Checklist Severity Scale. Started Dec 2002; status: completed.
02
Drugs
galantamine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00181675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00181675.